Additional information
White Powder
1315629-79-8
ACI-011232
NA
C33H34FN2NaO7
612.62
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
1b-(4-Fluorophenyl)hexahydro-?,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic Acid Sodium
1b-(4-Fluorophenyl)hexahydro-ß,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic Acid Sodium
Atorvastatin Cyclic (Fluorophenyl) Sodium Salt Impurity





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)